Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jul;158(1):164-173.
doi: 10.1016/j.chest.2020.02.049. Epub 2020 Mar 17.

Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis: The ORANGES Trial

Jose Iglesias  1 , Andrew V Vassallo  2 , Vishal V Patel  2 , Jesse B Sullivan  3 , Joseph Cavanaugh  2 , Yasmine Elbaga  4
Affiliations
Randomized Controlled Trial

Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis: The ORANGES Trial

Jose Iglesias et al. Chest. 2020 Jul.

Abstract

Background: Sepsis is a major public health burden resulting in 25% to 30% in-hospital mortality and accounting for over 20 billion dollars of US hospital costs.

Research question: Does hydrocortisone, ascorbic acid, thiamine (HAT) therapy improve clinical outcomes in sepsis and septic shock?

Study design and methods: This was a randomized, double-blinded, placebo-controlled trial conducted from February 2018 to June 2019, assessing an HAT treatment bundle for the management of septic and septic shock patients admitted to an ICU. The primary outcomes were resolution of shock and change in Sequential Organ Failure Assessment (SOFA) score. Secondary outcomes included 28-day mortality, ICU mortality, hospital mortality, procalcitonin clearance (PCT-c), hospital length of stay (LOS), ICU LOS, and ventilator-free days.

Results: One hundred thirty-seven patients were randomized to the treatment group (n = 68) and comparator group (n = 69), respectively, with no significant differences in baseline characteristics. A statistically significant difference was found in the time patients required vasopressors, indicating quicker reversal of shock in the HAT group compared with the comparator group (27 ± 22 vs 53 ± 38 hours, P < .001). No statistically significant change in SOFA score was found between groups 3 (1 - 6) vs 2 (0 - 4), P = .17. No significant differences were found between study arms in ICU and hospital mortality, ICU and hospital LOS, ventilator free days, and PCT-c.

Interpretation: Our results suggest that the combination of IV ascorbic acid, thiamine, and hydrocortisone significantly reduced the time to resolution of shock. Additional studies are needed to confirm these findings and assess any potential mortality benefit from this treatment.

Trial registration: ClinicalTrials.gov; No.: NCT03422159; URL: www.clinicaltrials.gov.

Keywords: HAT therapy; ascorbic acid; hydrocortisone; sepsis; septic shock; thiamine; vitamin c.

PubMed Disclaimer

Comment in

  • Additional Trials of Vitamin C in Septic Shock: A Bag of Mixed Fruit.
    Fujii T, Udy AA. Fujii T, et al. Chest. 2020 Jul;158(1):13-14. doi: 10.1016/j.chest.2020.03.030. Epub 2020 Jul 2. Chest. 2020. PMID: 32654701 No abstract available.
  • Vitamin C in Sepsis: The Road Ahead.
    Garg P, Tirlangi P, Arora U, Soneja M. Garg P, et al. Chest. 2021 Feb;159(2):879-880. doi: 10.1016/j.chest.2020.08.2101. Chest. 2021. PMID: 33563440 No abstract available.
  • Response.
    Iglesias J; ORANGES investigators. Iglesias J, et al. Chest. 2021 Feb;159(2):880-881. doi: 10.1016/j.chest.2020.09.002. Chest. 2021. PMID: 33563441 No abstract available.
  • HAT Therapy: Really Beneficial?
    Shiba H, Minami S, Shiraishi A. Shiba H, et al. Chest. 2021 Feb;159(2):881. doi: 10.1016/j.chest.2020.08.2100. Chest. 2021. PMID: 33563442 No abstract available.
  • Response.
    Iglesias J. Iglesias J. Chest. 2021 Feb;159(2):882. doi: 10.1016/j.chest.2020.09.001. Chest. 2021. PMID: 33563443 No abstract available.
  • [Focus general intensive care medicine. Intensive care studies from 2020/2021].
    Dietrich M, Beynon C, Fiedler MO, Bernhard M, Kümpers P, Hecker A, Jungk C, Nusshag C, Michalski D, Brenner T, Weigand MA, Reuß CJ. Dietrich M, et al. Anaesthesist. 2021 Oct;70(10):888-894. doi: 10.1007/s00101-021-00976-x. Epub 2021 Jul 29. Anaesthesist. 2021. PMID: 34324037 Free PMC article. German. No abstract available.

Publication types

Associated data